Global marketsUpdated November 12

A Hill opinion says rare risks matter at scale.

A Hill opinion makes a point about scale: even an uncommon complication could affect many people when a medication is prescribed to millions. Its title applies that concern to the risk of blindness from GLP-1 drugs. That is an argument for taking a possible risk seriously, not a new finding that the drugs cause NAION.

1 publisher1 report

Coverage started November 12